Top experts by indication / Infectious Disease
Most active experts in Sepsis / Serious Bacterial
2026 edition, data as of October 26, 2026
211 key opinion leaders in the directory are tagged to Sepsis / Serious Bacterial. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 27 of the 211 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Vance FowlerDuke University, NC | 6 trials |
| 2 | Stephanie TaylorLA | 2 trials |
| 3 | Stuart GoldsteinCincinnati Children's Hospital Medical Center, OH | 2 trials |
| 4 | Davidson HamerBoston University, MA | 2 trials |
| 5 | Matthew SemlerVanderbilt University Medical Center, TN | 2 trials |
| 6 | Issam RaadThe University of Texas MD Anderson Cancer Center, TX | 1 trial |
| 7 | Donald PoretzVA | 1 trial |
| 8 | Daniel FreilichBassett Medical Center, NY | 1 trial |
| 9 | Andrew BadleyMN | 1 trial |
| 10 | Lin ChenMount Auburn Hospital, MA | 1 trial |
| 11 | Fernanda SilveiraUniversity of Pittsburgh, PA | 1 trial |
| 12 | Ebbing LautenbachPA | 1 trial |
| 13 | Sara CosgroveMD | 1 trial |
| 14 | Edward SherwoodTX | 1 trial |
| 15 | Jose VazquezMedical College of Georgia, GA | 1 trial |
| 16 | Shahin LockmanHarvard T.H. Chan School of Public Health, MA | 1 trial |
| 17 | Mohamed OthmanBaylor College of Medicine, TX | 1 trial |
| 18 | David LeafBrigham and Women's Hospital, MA | 1 trial |
| 19 | Arun SanyalVirginia Commonwealth University (VCU) School of Medicine, VA | 1 trial |
| 20 | Pablo TebasUniversity of Pennsylvania, PA | 1 trial |
| 21 | Rebecca BaronBrigham and Women's Hospital, MA | 1 trial |
| 22 | Jerry KrishnanUniversity of Illinois Chicago, IL | 1 trial |
| 23 | Mary HaydenRush University, IL | 1 trial |
| 24 | Scott HeysellUniversity of Virginia School of Medicine, VA | 1 trial |
| 25 | Robert KanerWeill Cornell Medicine, NY | 1 trial |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 4 of the 211 people tagged to this indication have at least 2 registered trials in it and this count on record; the 4 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Vance FowlerDuke University, NC | 58,472 citations |
| 2 | Stuart GoldsteinCincinnati Children's Hospital Medical Center, OH | 36,897 citations |
| 3 | Davidson HamerBoston University, MA | 19,161 citations |
| 4 | Matthew SemlerVanderbilt University Medical Center, TN | 14,843 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 5 of the 211 people tagged to this indication have at least 2 registered trials in it and this count on record; the 5 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Vance FowlerDuke University, NC | 8 awards |
| 2 | Matthew SemlerVanderbilt University Medical Center, TN | 3 awards |
| 3 | Stephanie TaylorLA | 2 awards |
| 4 | Stuart GoldsteinCincinnati Children's Hospital Medical Center, OH | 2 awards |
| 5 | Davidson HamerBoston University, MA | 2 awards |
Emerging
10 of the 211 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Kayleen BaileyNY |
| Rubin CohenSUNY Upstate Medical University, TX |
| Vincent EsguerraThe Ohio State University, OH |
| Mercedes FalcigliaOH |
| Natalie JayaramChildren's Mercy Hospital, MO |
| Bhavika KaulMichael E. DeBakey VA Medical Center, TX |
| Nandita NadigNorthwestern University Feinberg School of Medicine, IL |
| Eva OtoupalovaVA |
| Ankit SakhujaIcahn School of Medicine at Mount Sinai, NY |
| Robert StarNational Institutes of Health, MD |
How these tables are computed
The cohort is every profile in the directory tagged to Sepsis / Serious Bacterial, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Sepsis / Serious Bacterial profile in the directory